Collection of Samples from the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance
Brief description of study
This study is designed to prospectively collect blood samples and clinical data from subjects that have a suspected advanced adenoma or have been newly diagnosed with colorectal cancer and scheduled for resection surgery, and subjects who are at average risk of colorectal cancer and who are scheduled for routine colonoscopy examinations.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Colorectal Cancer
-
Age: Between 45 Years - 85 Years
-
Gender: All
Male and Female Age 45-85
Updated on
09 Mar 2024.
Study ID: 844442
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
